AstraZeneca’s asthma drug gets regulator’s approval in China
China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.
Drugs
Health
Pharma
Drugs
Health
Pharma
EMA approves Sanofi’s treatment for obstructive pulmonary disease
The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary.
Drugs
Health
Pharma
Johnson & Johnson to buy Proteologix Inc., for $850 million in cash
HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to.
Drugs
Health
Medical
NO2 in gas and propane stoves can cause asthma in children: Study
HQ Team May 4, 2024: A new research says that nitrogen dioxide gas (NO2) emitted by gas and propane stoves is likely to.
Drugs
Health
Pharma
Israel’s Teva in pact with Launch Therapeutics for asthma drug
Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
Drugs
Health
Pharma
GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion
HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes.
Climate
Health
Pharma
Global air pollution wrecking human resistance to antibiotics
HQ Team August 13, 2023: Global air pollution can aid antibiotic resistance in humans, researchers from China and the UK found. They checked.
Medical
Pharma
Lupin buys inhalation brands from Sunovion for $75m
Lupin buys two inhalation brands for $75million